Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
A physical model of radiated enhancement of plasma-surrounded antenna
A physical and numerical investigation of the failure mechanism of weak rocks surrounding tunnels
A photoacoustic image reconstruction method using total variation and nonconvex optimization
A physiotherapist-delivered, combined exercise and pain coping skills training intervention for individuals with knee osteoarthritis: A pilot study
A phosphomolybdic acid anion probe-based label-free, stable and simple electrochemical biosensing platform
A pharmacist-led system-change smoking cessation intervention for smokers admitted to Australian public hospitals (GIVE UP FOR GOOD): study protocol for a randomised controlled trial
A phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial
A physiotherapy-directed occupational health programme for Austrian school teachers: a cluster randomised pilot study
A photoviscoplastic model for photoactivated covalent adaptive networks
A phenomenological memristor model for short-term/long-term memory
A physical model of sea wave period from altimeter data
A phase-1b study of everolimus plus paclitaxel in patients with small-cell lung cancer
A phylogenetic analysis and new delimitation of Senecio sect. Crociseris (Compositae: Senecioneae), with evidence of intergeneric hybridization
A photometric study of SDSS J081256.85+191157.8: Detection of orbital and negative superhump periods
A physiologically based kinetic model for bacterial sulfide oxidation
A phase-imaging technique for cyclotron-frequency measurements
A phenothiazine-diketopyrrolopyrrole polymer: Synthesis and photovoltaic applications
A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer
A photoswitchable bis-azo derivative with a high temporal resolution
A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function
A phase II study of hypofractionated proton therapy for prostate cancer
A phi-competitive algorithm for collecting items with increasing weights from a dynamic queue
A phantom for diffusion-weighted MRI (DW-MRI)
A phase I dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancer
A physicochemical model for the formation of gas hydrates of different structural types in K-2 mud volcano (Kukui Canyon, Lake Baikal)
A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomas
A phenornics approach to the analysis of the influence of glutathione on leaf area and abiotic stress tolerance in Arabidopsis thaliana
A physiologically based in silico model for trans-2-hexenal detoxification and DNA adduct formation in human including interindividual variation indicates efficient detoxification and a negligible genotoxicity risk
A phase II study of vorinostat (MK-0683) in patients with polycythaemia vera and essential thrombocythaemia
A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee
A phase I and pharmacokinetic study of oxaliplatin and bortezomib: activity, but dose-limiting neurotoxicity
A photospheric metal line profile analysis of hot DA white dwarfs with circumstellar material
A phenomenological study of the effects of clinical negligence litigation on midwives in England: The personal perspective
A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme
A phase II dose-ranging study of mirabegron in patients with overactive bladder
A phonetic explanation of pronunciation variant effects
A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors
A phase I trial of everolimus in combination with 5-FU/LV, mFOLFOX6 and mFOLFOX6 plus panitumumab in patients with refractory solid tumors
A phylogenetic re-evaluation of Phyllosticta (Botryosphaeriales)
A physical cross-linking process of cellulose nanofibril gels with shear-controlled fibril orientation
A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound, administered as a 24-h continuous infusion in patients with advanced solid tumors
A physiologically based kinetic (PBK) model describing plasma concentrations of quercetin and its metabolites in rats
A phylogenetic approach towards understanding the drivers of plant invasiveness on Robben Island, South Africa
A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: A Gynecologic Oncology Group study
A phase transformation route to Fe2O3-Mn3O4 nanocomposite with improved electrode performance
A phase I and pharmacokinetic study of capecitabine in combination with radiotherapy in patients with localised inoperable pancreatic cancer
A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis
A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer
A phytochemical comparison of saw palmetto products using gas chromatography and H-1 nuclear magnetic resonance spectroscopy metabolomic profiling
A phase I study of DHP107, a mucoadhesive lipid form of oral paclitaxel, in patients with advanced solid tumors: Crossover comparisons with intravenous paclitaxel
A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma
A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer
A phylogenetic analysis of genus Onobrychis and its relationships within the tribe Hedysareae (Fabaceae)
A phospho-BAD BH3 helix activates glucokinase by a mechanism distinct from that of allosteric activators
A phase 2, randomized, double-blind, multicenter study comparing siltuximab plus best supportive care (BSC) with placebo plus BSC in anemic patients with International Prognostic Scoring System low- or intermediate-1-risk myelodysplastic syndrome
A phased approach to enable hybrid simulation of complex structures
A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma
A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: A Gynecologic Oncology Group study
A photoelectron spectroscopy and ab initio study of the structures and chemical bonding of the B-25(-) cluster
A photoswitchable and thermally stable axially chiral dithienylperfluorocyclopentene dopant with high helical twisting power
A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma
A phosphatidylinositol transfer protein integrates phosphoinositide signaling with lipid droplet metabolism to regulate a developmental program of nutrient stress-induced membrane biogenesis
A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia
A photo-degradable gene delivery system for enhanced nuclear gene transcription
A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group study
A phase II trial of brivanib in recurrent or persistent enclometrial cancer: An NRG Oncology/Gynecologic Oncology Group Study
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib
A photo-triggered layered surface coating producing reactive oxygen species
A philosophical perspective on the relation between cortical midline structures and the self cortical midline structures and the self
A phylogenetic appraisal of Sigmodontinae (Rodentia, Cricetidae) with emphasis on phyllotine genera: systematics and biogeography
A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube
A phase I study of PRO131921, a novel anti-CD20 Monoclonal antibody in patients with relapsed/refractory CD20+indolent NHL: Correlation between clinical responses and AUC pharmacokinetics
A phase mixing model for the frequency-doubling illusion
A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma
A photonic glucose biosensor for chronic wound prognostics
A phase I clinical trial of Ad5/3-Delta 24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer
A phenomenological study into the impact of the sign-off mentor in the acute hospital setting
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung cancer
A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies
A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer
A phase I/II study piloting accelerated partial breast irradiation using CT-guided intensity modulated radiation therapy in the prone position
A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213